PTPN11 and juvenile myelomonocytic leukemia: The most common SHP2 GOF mutations are D61G [16] and E76D, which are present in approximately 50% of patients with Noonan syndrome (NS), a developmental disorder associated with an elevated risk of JMML [17, 18].